Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | EVAX |
---|---|---|
09:32 ET | 278 | 2.66 |
09:41 ET | 1380 | 2.67 |
09:52 ET | 750 | 2.7892 |
10:01 ET | 1100 | 2.8239 |
10:08 ET | 10600 | 2.8299 |
10:10 ET | 3403 | 2.82 |
10:21 ET | 9459 | 2.42 |
10:24 ET | 3531 | 2.8199 |
10:26 ET | 1148 | 2.6 |
10:28 ET | 4200 | 2.58 |
10:30 ET | 1141 | 2.75 |
10:32 ET | 1592 | 2.74 |
10:33 ET | 2107 | 2.55 |
10:35 ET | 2371 | 2.64 |
10:37 ET | 3100 | 2.6021 |
10:48 ET | 140 | 2.62 |
10:50 ET | 1304 | 2.63 |
10:51 ET | 1192 | 2.6786 |
11:22 ET | 100 | 2.66 |
11:44 ET | 1847 | 2.6 |
12:03 ET | 433 | 2.59 |
12:09 ET | 100 | 2.61 |
12:36 ET | 3000 | 2.6101 |
01:21 ET | 200 | 2.625 |
01:24 ET | 100 | 2.625 |
01:53 ET | 200 | 2.62 |
02:09 ET | 500 | 2.75 |
02:33 ET | 500 | 2.82 |
02:54 ET | 2150 | 2.624 |
02:58 ET | 2600 | 2.796 |
03:07 ET | 100 | 2.61 |
03:23 ET | 700 | 2.72 |
03:32 ET | 100 | 2.67 |
03:38 ET | 633 | 2.65 |
03:52 ET | 1932 | 2.63 |
03:56 ET | 100 | 2.63 |
03:59 ET | 654 | 2.63 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Evaxion Biotech A/S | 14.9M | -0.1x | --- |
Apollomics Inc | 14.9M | -0.2x | --- |
Imunon Inc | 14.6M | -0.5x | --- |
Inhibitor Therapeutics Inc | 14.6M | -4.8x | --- |
NRX Pharmaceuticals Inc | 15.8M | -0.9x | --- |
Protext Mobility Inc | 15.8M | 0.0x | --- |
Evaxion Biotech A/S is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $14.9M |
---|---|
Revenue (TTM) | $278.0K |
Shares Outstanding | 557.6K |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.24 |
EPS | $-36.98 |
Book Value | $-1.25 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 53.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -6,871.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.